Autolus Therapeutics plc, formerly Autolus Therapeutics Limited, is a development-stage biopharmaceutical company. The company is engaged in developing programmed T-cell therapies for the treatment of cancer. The Company's clinical-stage product cand... Read more
MarketWatch
MarketWatch
MarketWatch
CNBC
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.